News

High risk of metastatic recurrence among young cancer patients - Research highlights urgent need for tailored survivorship care

Study identifies target for disease hyper progression after immunotherapy in kidney cancer

Scientists develop one-product-fits-all immunotherapy for pancreatic cancer

Study suggests many men may not need long-term hormone therapy for prostate cancer

HER2-targeted therapy shows promising results in rare bile duct cancers

Liquid biopsy tool to guide early-stage gastric cancer treatment

Much-needed new drug approved for deadliest blood cancer

SISAQOL-IMI consortium publishes key paper and launches online materials to advance patient-reported outcomes in cancer clinical trials

Why monkey studies may mislead research on cancer immunotherapy drugs targeting TIGIT

Gut microbiome connects obesity to cancer, impacting public health

Researchers uncover key immune differences in triple-negative breast cancer

Synthetic stress hormone dexamethasone could reduce breast cancer metastases